W. H. Clark

3.4k total citations · 1 hit paper
19 papers, 2.6k citations indexed

About

W. H. Clark is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W. H. Clark has authored 19 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W. H. Clark's work include Cutaneous Melanoma Detection and Management (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunotherapy and Immune Responses (3 papers). W. H. Clark is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immunotherapy and Immune Responses (3 papers). W. H. Clark collaborates with scholars based in United States. W. H. Clark's co-authors include David E. Elder, DuPont Guerry, Martín C. Mihm, Bruce J. Trock, Leonard E. Braitman, Allan C. Halpern, D. Schultz, Marie Synnestvedt, Meenhard Herlyn and Ulrich Rodeck and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Obstetrics and Gynecology.

In The Last Decade

W. H. Clark

19 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Model Predicting Survival in Stage I Melanoma Based on Tumor Progression

1989 940 citations W. H. Clark, David E. Elder et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. H. Clark United States	17	1.8k	1.0k	754	370	345	19	2.6k
David E. Elder United States	33	2.4k 1.3×	1.2k 1.2×	474 0.6×	458 1.2×	532 1.5×	78	3.4k
Lyn M. Duncan United States	22	1.8k 1.0×	1.7k 1.6×	685 0.9×	686 1.9×	385 1.1×	41	3.3k
Toshiro Kageshita Japan	28	2.8k 1.5×	2.9k 2.9×	1.7k 2.3×	514 1.4×	600 1.7×	135	5.1k
Adriano Piris United States	27	2.0k 1.1×	1.8k 1.8×	606 0.8×	421 1.1×	224 0.6×	69	3.5k
Leslie A. Wanek United States	25	2.5k 1.4×	1.1k 1.1×	886 1.2×	243 0.7×	48 0.1×	34	2.9k
I. Funke Germany	22	2.0k 1.1×	1.1k 1.1×	573 0.8×	819 2.2×	360 1.0×	35	3.4k
Giandomenico Russo Italy	40	1.1k 0.6×	1.9k 1.9×	1.9k 2.5×	539 1.5×	137 0.4×	93	4.6k
Michael D. Onken United States	29	1.5k 0.8×	2.5k 2.5×	1.1k 1.5×	618 1.7×	509 1.5×	49	4.8k
Kerry A. Crotty Australia	18	1.7k 0.9×	548 0.5×	254 0.3×	198 0.5×	154 0.4×	40	2.0k
Lutz Riethdorf Germany	26	1.1k 0.6×	831 0.8×	269 0.4×	667 1.8×	71 0.2×	55	2.5k

Countries citing papers authored by W. H. Clark

Since Specialization

Citations

This map shows the geographic impact of W. H. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. H. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. H. Clark more than expected).

Fields of papers citing papers by W. H. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. H. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. H. Clark. The network helps show where W. H. Clark may publish in the future.

Co-authorship network of co-authors of W. H. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of W. H. Clark. A scholar is included among the top collaborators of W. H. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. H. Clark. W. H. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Kao, Grace F., Terence J. Harrist, Barbara E. Shapiro, & W. H. Clark. (1997). Malignant Melanoma Arising in Association with an Adnexal Neoplasm Showing Features of Trlchoblastoma (Collision Tumor): A Clinicopathologic Study of Two Cases.. American Journal of Dermatopathology. 19(4). 429–430. 2 indexed citations

2.

Goldstein, Alisa M., Lynn R. Goldin, Nicholas C. Dracopoli, W. H. Clark, & Margaret A. Tucker. (1996). Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.. PubMed. 58(5). 1050–6. 38 indexed citations

3.

Goldstein, Alisa M., Mary C. Fraser, W. H. Clark, & Miriam Tucker. (1994). Age at Diagnosis and Transmission of Invasive Melanoma in 23 Families With Cutaneous Malignat Melanoma/Dysplastic Nevi. JNCI Journal of the National Cancer Institute. 86(18). 1385–1390. 30 indexed citations

4.

Goldstein, Alisa M., Nicholas C. Dracopoli, Marcy Engelstein, et al.. (1994). Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.. PubMed. 54(3). 489–96. 88 indexed citations

5.

Goldstein, Alisa M., Nicholas C. Dracopoli, Mary C. Fraser, et al.. (1993). Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity.. PubMed. 52(3). 537–50. 89 indexed citations

6.

Goldstein, Alisa M., Nicholas C. Dracopoli, Mary C. Fraser, et al.. (1993). Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p. 1 indexed citations

7.

Clark, W. H.. (1991). Tumour progression and the nature of cancer. British Journal of Cancer. 64(4). 631–644. 222 indexed citations

8.

Mancianti, Maria‐Laura, W. H. Clark, F. Ann Hayes, & Meenhard Herlyn. (1990). Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype.. PubMed. 136(4). 817–29. 66 indexed citations

9.

Clark, W. H., David E. Elder, DuPont Guerry, et al.. (1989). Model Predicting Survival in Stage I Melanoma Based on Tumor Progression. JNCI Journal of the National Cancer Institute. 81(24). 1893–1904. 940 indexed citations breakdown →

10.

Iliopoulos, Dimitrios, Carolyn S. Ernst, Z Steplewski, et al.. (1989). Inhibition of Metastases of a Human Melanoma Xenograft by Monoclonal Antibody to the GD2/GD3 Gangliosides. JNCI Journal of the National Cancer Institute. 81(6). 440–444. 68 indexed citations

11.

Elder, David E., Ulrich Rodeck, Jan Thurin, et al.. (1989). Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.. PubMed. 49(18). 5091–6. 116 indexed citations

12.

Herlyn, Meenhard, W. H. Clark, Ulrich Rodeck, et al.. (1987). Biology of tumor progression in human melanocytes.. PubMed. 56(5). 461–74. 193 indexed citations

13.

Herlyn, Meenhard, Jan Thurin, Gloria Balaban, et al.. (1985). Characteristics of cultured human melanocytes isolated from different stages of tumor progression.. PubMed. 45(11 Pt 2). 5670–6. 223 indexed citations

14.

Koh, H K, A J Sober, R A Lew, et al.. (1984). Lentigo maligna melanoma has no better prognosis than other types of melanoma.. Journal of Clinical Oncology. 2(9). 994–1001. 106 indexed citations

15.

Thompson, John J., Meenhard Herlyn, D Elder, et al.. (1982). Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.. PubMed. 107(3). 357–61. 38 indexed citations

16.

Clark, W. H.. (1978). Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Archives of Dermatology. 114(5). 732–738. 97 indexed citations

17.

Federman, Jay L., et al.. (1974). Brief Communication: Tumor-Associated Antibodies to Ocular and Cutaneous Malignant Melanomas: Negative Interaction With Normal Choroidal Melanocytes2. JNCI Journal of the National Cancer Institute. 52(2). 587–589. 16 indexed citations

18.

Clark, W. H. & Martín C. Mihm. (1969). Lentigo maligna and lentigo-maligna melanoma.. PubMed. 55(1). 39–67. 246 indexed citations

19.

Krupp, Philip J., et al.. (1961). Malignant mixed Müllerian neoplasms (mixed mesodermal tumors). American Journal of Obstetrics and Gynecology. 81(5). 959–969. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact